论文部分内容阅读
目的:探讨2型糖尿病采用甘精胰岛素联合阿卡波糖治疗效果。方法:本次共选择100例2型糖尿病患者作研究对象,均为我院2012年9月~2013年9月收治,采用数字表抽取法随机分组,就甘精胰岛素联合阿卡波糖(观察组,n=50)与单用门冬胰岛素(对照组,n=50)效果进行比较。结果:治疗前2组EPG指标、2hPG指标、HbA1c指标差异均不明显(P>0.05)。治疗后上述各指标水平均低于对照组,有统计学差异(P<0.05)。观察组经统计示血糖达标时间略短于对照组,但不具统计学意义(P>0.05)。观察组低血糖率为2%,对照组为12%,差异有显著统计学意义(P<0.05)。结论:2型糖尿病采用甘精胰岛素与阿卡波糖联合治疗,疗效后,可使低血糖有效降低,无明显不良反应,具较高应用价值。
Objective: To investigate the effect of insulin glargine combined with acarbose on type 2 diabetes mellitus. Methods: A total of 100 patients with type 2 diabetes mellitus were enrolled in this study. All of them were treated in our hospital from September 2012 to September 2013. The patients were randomly divided into groups according to the digital table extraction method. Group, n = 50) compared with insulin aspart alone (control group, n = 50). Results: There was no significant difference in EPG index, 2hPG index and HbA1c index between the two groups before treatment (P> 0.05). After treatment, the above indicators were lower than the control group, with statistical significance (P <0.05). The observation group showed that the blood sugar standard time slightly shorter than the control group, but not statistically significant (P> 0.05). The observation group had a hypoglycemia rate of 2% and a control group of 12%, the difference was statistically significant (P <0.05). Conclusion: Type 2 diabetes treated with insulin glargine and acarbose, after treatment, can effectively reduce hypoglycemia, no obvious adverse reactions, with high value.